Virtu Financial’s Regenxbio RGNX Stock Holding History

Virtu Financial’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$97K	Buy	+11,614	New	+$122K	﹤0.01%	1198
2025 Q3	–	Sell	-29,543	Closed	-$243K	–	1983
2025 Q2	$243K	Buy	+29,543	New	+$247K	0.01%	842
2024 Q1	–	Sell	-20,988	Closed	-$377K	–	1979
2023 Q4	$377K	Buy	+20,988	New	+$370K	0.03%	504
2021 Q1	–	Sell	-9,698	Closed	-$440K	–	1953
2020 Q4	$440K	Buy	+9,698	New	+$339K	0.05%	477
2017 Q4	–	Sell	-37,417	Closed	-$1.23M	–	2901
2017 Q3	$1.23M	Buy	+37,417	New	+$842K	0.06%	355

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's RGNX Position: Q1 2026 in Review

Virtu Financial opened a new position in Regenxbio (RGNX) in Q1 2026: 11,614 shares worth $97K. The stake represents ﹤0.01% of the portfolio and ranks #1198 among its holdings. This is a return to the name: Virtu Financial previously reported a position in RGNX as recently as Q2 2025.

Virtu Financial first reported a position in RGNX in Q3 2017 and has held it in 5 quarters since. The position peaked at $1.23M in Q3 2017. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

Virtu Financial held 11,614 shares of Regenxbio worth $97K as of Q1 2026.
Regenxbio was a new Virtu Financial position in Q1 2026.
Regenxbio made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1198 holding.
Virtu Financial first reported a position in Regenxbio in Q3 2017 and has held it in 5 quarters since.
Virtu Financial's Regenxbio position peaked at $1.23M in Q3 2017.
178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.